Vertex Pharmaceuticals, Inc. (VRTX)
441.88
+5.95
(+1.36%)
USD |
NASDAQ |
May 27, 13:56
Vertex Pharmaceuticals Free Cash Flow : 3.710B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Biogen, Inc. | 2.316B |
| Gilead Sciences, Inc. | 10.23B |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Moderna, Inc. | -1.603B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.428B |
| Cash from Investing (Quarterly) | -431.90M |
| Cash from Financing (Quarterly) | -538.80M |
| Free Cash Flow Per Share (Quarterly) | 5.052 |
| Free Cash Flow to Equity (Quarterly) | 1.344B |
| Free Cash Flow to Firm (Quarterly) | 1.295B |
| Free Cash Flow Yield | 3.26% |